These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Expression and distribution of osteopontin in human tissues: widespread association with luminal epithelial surfaces. Brown LF; Berse B; Van de Water L; Papadopoulos-Sergiou A; Perruzzi CA; Manseau EJ; Dvorak HF; Senger DR Mol Biol Cell; 1992 Oct; 3(10):1169-80. PubMed ID: 1421573 [TBL] [Abstract][Full Text] [Related]
28. Inhibition of nuclear factor-kappaB activation by pyrrolidine dithiocarbamate prevents chronic FK506 nephropathy. Tamada S; Nakatani T; Asai T; Tashiro K; Komiya T; Sumi T; Okamura M; Kim S; Iwao H; Kishimoto T; Yamanaka S; Miura K Kidney Int; 2003 Jan; 63(1):306-14. PubMed ID: 12472797 [TBL] [Abstract][Full Text] [Related]
29. Induction of MIF synthesis and secretion by tubular epithelial cells: a novel action of angiotensin II. Rice EK; Tesch GH; Cao Z; Cooper ME; Metz CN; Bucala R; Atkins RC; Nikolic-Paterson DJ Kidney Int; 2003 Apr; 63(4):1265-75. PubMed ID: 12631343 [TBL] [Abstract][Full Text] [Related]
30. Ultrastructural immunodetection of osteopontin and osteocalcin as major matrix components of renal calculi. McKee MD; Nanci A; Khan SR J Bone Miner Res; 1995 Dec; 10(12):1913-29. PubMed ID: 8619372 [TBL] [Abstract][Full Text] [Related]
32. Protein kinase Cbeta inhibition attenuates osteopontin expression, macrophage recruitment, and tubulointerstitial injury in advanced experimental diabetic nephropathy. Kelly DJ; Chanty A; Gow RM; Zhang Y; Gilbert RE J Am Soc Nephrol; 2005 Jun; 16(6):1654-60. PubMed ID: 15843473 [TBL] [Abstract][Full Text] [Related]
33. Albumin up-regulates the type II transforming growth factor-beta receptor in cultured proximal tubular cells. Wolf G; Schroeder R; Ziyadeh FN; Stahl RA Kidney Int; 2004 Nov; 66(5):1849-58. PubMed ID: 15496155 [TBL] [Abstract][Full Text] [Related]
34. Upregulation of osteopontin expression in renal cortex of streptozotocin-induced diabetic rats is mediated by bradykinin. Fischer JW; Tschöpe C; Reinecke A; Giachelli CM; Unger T Diabetes; 1998 Sep; 47(9):1512-8. PubMed ID: 9726243 [TBL] [Abstract][Full Text] [Related]
35. Cellular proliferation and macrophage influx precede interstitial fibrosis in cyclosporine nephrotoxicity. Young BA; Burdmann EA; Johnson RJ; Alpers CE; Giachelli CM; Eng E; Andoh T; Bennett WM; Couser WG Kidney Int; 1995 Aug; 48(2):439-48. PubMed ID: 7564111 [TBL] [Abstract][Full Text] [Related]
36. Insulin-like growth factor I-enhanced renal expression of osteopontin after acute ischemic injury in rats. Padanilam BJ; Martin DR; Hammerman MR Endocrinology; 1996 May; 137(5):2133-40. PubMed ID: 8612558 [TBL] [Abstract][Full Text] [Related]
37. Identification of the major phosphoprotein secreted by many rodent cell lines as 2ar/osteopontin: enhanced expression in H-ras-transformed 3T3 cells. Craig AM; Nemir M; Mukherjee BB; Chambers AF; Denhardt DT Biochem Biophys Res Commun; 1988 Nov; 157(1):166-73. PubMed ID: 3058125 [TBL] [Abstract][Full Text] [Related]
38. Progression of tubulointerstitial injury by osteopontin-induced macrophage recruitment in advanced diabetic nephropathy of transgenic (mRen-2)27 rats. Kelly DJ; Wilkinson-Berka JL; Ricardo SD; Cox AJ; Gilbert RE Nephrol Dial Transplant; 2002 Jun; 17(6):985-91. PubMed ID: 12032186 [TBL] [Abstract][Full Text] [Related]
39. Osteopontin gene expression and protein synthesis in cultured rat mesangial cells. Nagasaki T; Ishimura E; Shioi A; Jono S; Inaba M; Nishizawa Y; Morii H; Otani S Biochem Biophys Res Commun; 1997 Apr; 233(1):81-5. PubMed ID: 9144400 [TBL] [Abstract][Full Text] [Related]
40. Effects of cyclosporine in osteopontin null mice. Mazzali M; Hughes J; Dantas M; Liaw L; Steitz S; Alpers CE; Pichler RH; Lan HY; Giachelli CM; Shankland SJ; Couser WG; Johnson RJ Kidney Int; 2002 Jul; 62(1):78-85. PubMed ID: 12081566 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]